Literature DB >> 2112278

Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay.

T Katayama1, S Kikuchi, Y Tanaka, I Saito, T Miyamura, Q L Choo, M Houghton, G Kuo.   

Abstract

Hepatitis C virus (HCV) antibody was detected in 1499 donor sera by radioimmunoassay using an antigen expressed in yeast from a cDNA clone of the HCV genome. Eighteen samples over 4200 counts per minute (cpm) were considered to contain infectious HCV because these recipients developed typical posttransfusion non-A, non-B hepatitis after transfusion. The antibody-positive sera were all within the normal range of ALT levels. This assay system is thus useful for the screening for blood transfusion.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2112278     DOI： 10.1046/j.1537-2995.1990.30490273448.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


  10 in total

Review 1.  Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan.

Authors:  K Kiyosawa; S Furuta
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Detection of hepatitis C virus antibody in patients with autoimmune hepatitis and other chronic liver diseases.

Authors:  M Onji; T Kikuchi; K Michitaka; I Saito; T Miyamura; Y Ohta
Journal:  Gastroenterol Jpn       Date:  1991-04

3.  Intrafamilial transmission of hepatitis C virus in Japan.

Authors:  K Michitaka; M Onji; N Horiike; K Kajino; I Saito; T Miyamura; Y Ohta
Journal:  Gastroenterol Jpn       Date:  1991-10

4.  Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome.

Authors:  W H Chou; T Yoneyama; K Takeuchi; H Harada; I Saito; T Miyamura
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

5.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.

Authors:  I Saito; T Miyamura; A Ohbayashi; H Harada; T Katayama; S Kikuchi; Y Watanabe; S Koi; M Onji; Y Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Evaluation of three hepatitis C virus-related antibodies C100, KCL-163, JCC. Tests for screening blood donors.

Authors:  S Fujiyama; S Kawano; S Sato; T Sato; T Kawahara; K Mizuno; Y Kusumoto; M Esumi; T Shikata
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

Review 7.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus.

Authors:  J Chiba; H Ohba; Y Matsuura; Y Watanabe; T Katayama; S Kikuchi; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

9.  Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.

Authors:  D Y Chien; Q L Choo; A Tabrizi; C Kuo; J McFarland; K Berger; C Lee; J R Shuster; T Nguyen; D L Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Development of a specific enzyme-linked immunosorbent assay for the hepatitis C virus antibody using clone 14.

Authors:  M Oketani; H Kawabata; S Imamura; E Maeda; H Tsubouchi; T Arima
Journal:  Gastroenterol Jpn       Date:  1993-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.